• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金刚烷胺衍生物和天然多胺对功能重组的流感病毒M2质子通道蛋白的不同抑制模式。

Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein.

作者信息

Lin T I, Heider H, Schroeder C

机构信息

Institut für Medizinische Virologie, Universitätsklinikum Charité, Humboldt-Universität zu Berlin, Germany.

出版信息

J Gen Virol. 1997 Apr;78 ( Pt 4):767-74. doi: 10.1099/0022-1317-78-4-767.

DOI:10.1099/0022-1317-78-4-767
PMID:9129648
Abstract

The influenza virus M2 protein, target of the antiviral drugs amantadine and rimantadine, forms a proton channel which functions during virus uncoating and maturation by modifying the pH in virions as well as in trans-Golgi vesicles. We studied the influence of different ionic gradients on the inhibition of the proton translocation activity of isolated, baculovirus-expressed M2 protein reconstituted into liposomes. Two distinct patterns of inhibition were observed. A group of amphiphilic amines including amantadine, cyclooctylamine and rimantadine inhibited M2 effectively in the presence of physiological Na+ concentrations. The 10-fold greater activity of rimantadine over amantadine and the 100-fold stronger effect of cyclooctylamine compared to cyclopentylamine matched the relative activities in influenza virus-infected cells. A completely different inhibitory pattern emerged for the polyamines spermine, spermidine and putrescine. Polyamines have recently been identified as the 'intrinsic' rectifiers of a class of potassium channels and shown to interact with acidic amino acid residues lining and flanking the channel pore. In the presence of a physiological Na+/K+ gradient their minimal inhibitory concentrations for influenza virus M2 protein were 100, 400 and 500 microM, polyamine levels reported to exist in oocytes. In conditions depleted for Na+, polyamines inhibited M2 at concentrations two to three orders of magnitude lower. The data suggest that influenza virus M2 protein possesses a binding site for polyamines, distinct from the amantadine binding site, which is normally masked by Na+ and which could be targeted by selective antiviral inhibitors.

摘要

流感病毒M2蛋白是抗病毒药物金刚烷胺和甲基金刚烷胺的作用靶点,它形成一个质子通道,在病毒脱壳和成熟过程中发挥作用,通过改变病毒粒子以及反式高尔基体囊泡中的pH值来实现。我们研究了不同离子梯度对重组到脂质体中的、杆状病毒表达的分离M2蛋白质子转运活性抑制的影响。观察到两种不同的抑制模式。一组两亲性胺类,包括金刚烷胺、环辛胺和甲基金刚烷胺,在生理Na+浓度存在的情况下能有效抑制M2。甲基金刚烷胺的活性比金刚烷胺高10倍,环辛胺的作用效果比环戊胺强100倍,这与它们在流感病毒感染细胞中的相对活性相符。对于多胺类物质精胺、亚精胺和腐胺,出现了完全不同的抑制模式。多胺类物质最近被确定为一类钾通道的“内在”整流器,并显示与通道孔内衬及侧翼的酸性氨基酸残基相互作用。在生理Na+/K+梯度存在的情况下,它们对流感病毒M2蛋白的最小抑制浓度分别为100、400和500微摩尔,这是据报道卵母细胞中存在的多胺水平。在Na+耗尽的条件下,多胺类物质以低两到三个数量级的浓度抑制M2。数据表明,流感病毒M2蛋白拥有一个多胺类物质结合位点,与金刚烷胺结合位点不同,该位点通常被Na+掩盖,并且可能成为选择性抗病毒抑制剂的作用靶点。

相似文献

1
Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein.金刚烷胺衍生物和天然多胺对功能重组的流感病毒M2质子通道蛋白的不同抑制模式。
J Gen Virol. 1997 Apr;78 ( Pt 4):767-74. doi: 10.1099/0022-1317-78-4-767.
2
Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.病毒M2离子通道蛋白:抗流感药物研发的一个有前景的靶点。
Mini Rev Med Chem. 2014;14(10):819-30.
3
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.一种M2-V27A通道阻滞剂对金刚烷胺敏感和耐药的甲型流感病毒均表现出强大的体外和体内抗病毒活性。
Antiviral Res. 2017 Apr;140:45-54. doi: 10.1016/j.antiviral.2017.01.006. Epub 2017 Jan 10.
4
Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.设计针对 H1N1 猪流感病毒的 M2 质子通道抑制剂。
PLoS One. 2010 Feb 23;5(2):e9388. doi: 10.1371/journal.pone.0009388.
5
Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.用于探索两种病毒离子通道蛋白结构的对称二聚金刚烷:流感病毒M2和丙型肝炎病毒p7
Drug Des Devel Ther. 2018 Apr 30;12:1019-1031. doi: 10.2147/DDDT.S157104. eCollection 2018.
6
Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus.将质子选择性和阿托安培单位电流明确分配给甲型流感病毒的M2离子通道蛋白。
J Virol. 2001 Apr;75(8):3647-56. doi: 10.1128/JVI.75.8.3647-3656.2001.
7
Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity.杆状病毒表达的流感病毒M2蛋白在脂质囊泡中的功能重建:质子转移活性的证据。
J Gen Virol. 1994 Dec;75 ( Pt 12):3477-84. doi: 10.1099/0022-1317-75-12-3477.
8
Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.设计和合成金刚烷胺衍生物作为抗流感 A M2 离子通道抑制剂。
Antiviral Res. 2012 Nov;96(2):91-9. doi: 10.1016/j.antiviral.2012.09.001. Epub 2012 Sep 13.
9
How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?金刚烷胺类如何阻断流感 M2 通道,以及耐药性是如何产生的?
J Am Chem Soc. 2011 Jun 29;133(25):9903-11. doi: 10.1021/ja202288m. Epub 2011 May 16.
10
Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels.用于阻断甲型流感 M2 野生型和 S31N 通道的化学探针。
ACS Chem Biol. 2020 Sep 18;15(9):2331-2337. doi: 10.1021/acschembio.0c00553. Epub 2020 Aug 27.

引用本文的文献

1
Mechanism and Kinetics of Copper Complexes Binding to the Influenza A M2 S31N and S31N/G34E Channels.铜配合物与流感 A M2 S31N 和 S31N/G34E 通道结合的机制和动力学。
Biophys J. 2021 Jan 5;120(1):168-177. doi: 10.1016/j.bpj.2020.11.016. Epub 2020 Nov 26.
2
Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors-In Vitro, In Silico and QSAR Studies.金刚烷胺的合成类似物作为流感病毒抑制剂的研究-体外、计算机模拟和定量构效关系研究。
Molecules. 2020 Sep 1;25(17):3989. doi: 10.3390/molecules25173989.
3
Diverse Functions of Polyamines in Virus Infection.
多胺在病毒感染中的多种功能。
Biomolecules. 2020 Apr 18;10(4):628. doi: 10.3390/biom10040628.
4
Progress of small molecular inhibitors in the development of anti-influenza virus agents.抗流感病毒药物研发中小分子抑制剂的进展
Theranostics. 2017 Feb 8;7(4):826-845. doi: 10.7150/thno.17071. eCollection 2017.
5
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.具有抗流感活性的化合物:流感最佳治疗与管理策略的现状与未来。第二部分:抗流感病毒的未来化合物
J Prev Med Hyg. 2014 Dec;55(4):109-29.
6
New vaccines against influenza virus.新型流感病毒疫苗
Clin Exp Vaccine Res. 2014 Jan;3(1):12-28. doi: 10.7774/cevr.2014.3.1.12. Epub 2013 Dec 18.
7
Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay.使用高通量酵母生长恢复测定法发现的流感 A 病毒 M2 质子通道抑制剂。
PLoS One. 2013;8(2):e55271. doi: 10.1371/journal.pone.0055271. Epub 2013 Feb 1.
8
Virus-like particles as universal influenza vaccines.病毒样颗粒作为通用流感疫苗。
Expert Rev Vaccines. 2012 Aug;11(8):995-1007. doi: 10.1586/erv.12.70.
9
Functional reconstitution of influenza A M2(22-62).甲型流感病毒M2(22 - 62)的功能重建
Biochim Biophys Acta. 2011 Feb;1808(2):516-21. doi: 10.1016/j.bbamem.2010.10.010. Epub 2010 Oct 20.
10
Proton and cation transport activity of the M2 proton channel from influenza A virus.甲型流感病毒 M2 质子通道的质子和阳离子转运活性。
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15409-14. doi: 10.1073/pnas.1009997107. Epub 2010 Aug 16.